You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Zhejiang Jutai Pharm Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ZHEJIANG JUTAI PHARM, and what generic and branded alternatives to ZHEJIANG JUTAI PHARM drugs are available?

ZHEJIANG JUTAI PHARM has three approved drugs.

Summary for Zhejiang Jutai Pharm

US Patents:	0
Tradenames:	3
Ingredients:	3
NDAs:	3

Drugs and US Patents for Zhejiang Jutai Pharm

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Zhejiang Jutai Pharm	AMANTADINE HYDROCHLORIDE	amantadine hydrochloride	TABLET;ORAL	218598-001	Sep 26, 2024	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Zhejiang Jutai Pharm	BUPROPION HYDROCHLORIDE	bupropion hydrochloride	TABLET, EXTENDED RELEASE;ORAL	211200-001	Sep 5, 2019	AB3	RX	No	No		⤷ Sign Up				⤷ Sign Up
Zhejiang Jutai Pharm	METOPROLOL SUCCINATE	metoprolol succinate	TABLET, EXTENDED RELEASE;ORAL	214110-001	Jul 26, 2024	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Zhejiang Jutai Pharm	METOPROLOL SUCCINATE	metoprolol succinate	TABLET, EXTENDED RELEASE;ORAL	214110-002	Jul 26, 2024	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Zhejiang Jutai Pharm	BUPROPION HYDROCHLORIDE	bupropion hydrochloride	TABLET, EXTENDED RELEASE;ORAL	211200-002	Apr 29, 2020	AB3	RX	No	No		⤷ Sign Up				⤷ Sign Up
Zhejiang Jutai Pharm	METOPROLOL SUCCINATE	metoprolol succinate	TABLET, EXTENDED RELEASE;ORAL	214110-003	Jul 26, 2024	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.